AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 168 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,904 | -18.7% | 11,433 | -72.8% | 0.00% | – |
| Q1 2023 | $58,896 | -29.2% | 41,979 | 0.0% | 0.00% | – |
| Q4 2022 | $83,129 | +1.4% | 41,979 | +6.4% | 0.00% | – |
| Q3 2022 | $82,000 | -61.7% | 39,443 | -40.1% | 0.00% | – |
| Q2 2022 | $214,000 | -9.3% | 65,903 | +17.3% | 0.00% | – |
| Q1 2022 | $236,000 | -13.2% | 56,168 | +0.1% | 0.00% | – |
| Q4 2021 | $272,000 | +205.6% | 56,107 | +199.2% | 0.00% | – |
| Q2 2020 | $89,000 | +29.0% | 18,751 | -8.7% | 0.00% | – |
| Q1 2020 | $69,000 | -80.3% | 20,549 | -71.8% | 0.00% | -100.0% |
| Q4 2019 | $351,000 | +0.3% | 72,980 | -39.6% | 0.00% | 0.0% |
| Q3 2019 | $350,000 | -21.3% | 120,774 | +285.2% | 0.00% | 0.0% |
| Q1 2019 | $445,000 | +27.1% | 31,356 | +20.9% | 0.00% | 0.0% |
| Q4 2018 | $350,000 | -44.9% | 25,937 | -9.4% | 0.00% | 0.0% |
| Q3 2018 | $635,000 | +55.3% | 28,613 | +14.9% | 0.00% | 0.0% |
| Q2 2018 | $409,000 | – | 24,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |